GO:0045338 farnesyl diphosphate metabolic process: Isoprenoid Biosynthesis Hub, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0045338 describes the chemical reactions and pathways involving farnesyl diphosphate (FPP), a central intermediate in carotenoid, sesquiterpene, squalene and sterol biosynthesis, and a substrate for protein farnesylation.
• FPP is synthesized by farnesyl diphosphate synthase (FDPS) and serves as a branch-point metabolite for cholesterol, ubiquinone, dolichol, heme A, and prenylated proteins.
• FDPS is a therapeutic vulnerability in hepatocellular carcinoma, where single-cell mapping of cholesterol metabolism identifies FDPS as a target.
• Mevalonate pathway metabolites, including FPP, boost aged oocyte quality through prenylation of small GTPases, linking this process to reproductive aging.
• TNF inhibitors target a mevalonate metabolite/TRPM2/calcium signaling axis in neutrophils, connecting FPP metabolism to Behçet's disease vasculitis.
• In plants and apicomplexan parasites, dedicated FPP synthases and bifunctional FPP/GGPP synthases are key for sesquiterpene biosynthesis and are targets of bisphosphonates [4,5,8].
Description
Farnesyl diphosphate metabolic process (GO:0045338) encompasses the chemical reactions and pathways involving farnesyl diphosphate (FPP), a 15-carbon isoprenoid intermediate that sits at the crossroads of multiple biosynthetic routes. FPP is produced by the condensation of isopentenyl diphosphate (IPP) and dimethylallyl diphosphate (DMAPP) and is then partitioned into carotenoid, sesquiterpene, squalene and sterol biosynthesis, as well as serving as a substrate for protein farnesylation. This process is fundamental to cellular metabolism because it supplies precursors for cholesterol, ubiquinone, dolichol, heme A, and prenylated proteins that control membrane trafficking and signal transduction. Researchers study GO:0045338 because dysregulation of FPP metabolism contributes to cancer, cardiovascular disease, and inflammatory disorders. For example, single-cell mapping of cholesterol metabolism has revealed FDPS, the enzyme that synthesizes FPP, as a therapeutic vulnerability in hepatocellular carcinoma. In aged oocytes, mevalonate metabolites including FPP boost quality through prenylation of small GTPases, highlighting a role in reproductive aging. In Behçet's disease, TNF inhibitors target a mevalonate metabolite/TRPM2/calcium signaling axis in neutrophils, linking FPP metabolism to vasculitis. Beyond human health, FPP metabolism is central to plant sesquiterpene biosynthesis and to apicomplexan parasites. Dedicated farnesyl diphosphate synthases in Zea mays circumvent isoprenoid-derived growth-defense tradeoffs, and plastidial engineering with coupled FPP pool reconstitution enhances sesquiterpene biosynthesis in tomato fruit. In Toxoplasma gondii, the bifunctional farnesyl-diphosphate/geranylgeranyl-diphosphate synthase is a molecular target of bisphosphonates. Thus, GO:0045338 is a research hub spanning oncology, immunology, plant biology, and parasitology.
farnesyl diphosphate metabolic process At A Glance
| GO ID | GO:0045338 |
|---|---|
| GO term | farnesyl diphosphate metabolic process |
| Ontology | biological_process |
| Synonym | farnesyl diphosphate metabolism |
| Definition | The chemical reactions and pathways involving farnesyl diphosphate, an intermediate in carotenoid, sesquiterpene, squalene and sterol biosynthesis, as well as a substrate in protein farnesylation. |
| Major function | Production and utilization of farnesyl diphosphate for isoprenoid biosynthesis and protein prenylation. |
| Key enzyme | Farnesyl diphosphate synthase (FDPS) catalyzes the formation of FPP from IPP and DMAPP. |
| Pathway context | Mevalonate pathway branch point leading to cholesterol, ubiquinone, dolichol, heme A, and prenylated proteins. |
| Disease relevance | Cancer, reproductive aging, inflammatory vasculitis, and parasitic infections. |
What Is GO:0045338?
GO:0045338, farnesyl diphosphate metabolic process, is defined as the chemical reactions and pathways involving farnesyl diphosphate, an intermediate in carotenoid, sesquiterpene, squalene and sterol biosynthesis, as well as a substrate in protein farnesylation. In practical terms, it covers the synthesis of FPP from IPP and DMAPP, its conversion into downstream isoprenoids such as squalene and sterols, and its use in prenylation reactions that attach farnesyl groups to proteins. The term is a biological process in the Gene Ontology and is synonymous with farnesyl diphosphate metabolism.
Why Is farnesyl diphosphate metabolic process Important in Cell Biology?
GO:0045338 is important because FPP is a central metabolic node whose flux determines the output of the mevalonate pathway, affecting cholesterol synthesis, protein prenylation, and the production of essential isoprenoids. Disruption of FPP metabolism alters cell proliferation, survival, and differentiation, and has been implicated in cancer, immune disorders, and aging [1,3,6]. Understanding this process provides a foundation for therapeutic targeting of FDPS and related enzymes in oncology and inflammation, and for metabolic engineering of sesquiterpene production in plants [5,6].
• FPP is the branch-point intermediate for cholesterol and non-sterol isoprenoids such as ubiquinone, dolichol, and heme A.
• FDPS, the enzyme producing FPP, is a therapeutic vulnerability in hepatocellular carcinoma identified by single-cell mapping.
• Mevalonate metabolites including FPP improve aged oocyte quality via prenylation of small GTPases.
• TNF inhibitors modulate a mevalonate metabolite/TRPM2/calcium axis in neutrophils, linking FPP to Behçet's disease vasculitis.
• Dedicated FPP synthases in maize balance growth and defense by channeling isoprenoids into distinct pathways.
• Plastidial engineering of FPP pools enhances sesquiterpene biosynthesis in tomato fruit.
• The bifunctional FPP/GGPP synthase of Toxoplasma gondii is a target of bisphosphonates, relevant to antiparasitic drug development.
• Protein farnesylation, which uses FPP as a substrate, controls localization and function of small GTPases such as RAS.
• FPP metabolism intersects with calcium signaling and inflammatory pathways in neutrophils.
• Altered FPP flux can affect cell cycle progression and apoptosis, making it a focus in cancer research.
What Happens During farnesyl diphosphate metabolic process?
Synthesis of farnesyl diphosphate by FDPS
In simple terms: The cell builds FPP by joining two smaller molecules together.
Farnesyl diphosphate synthase (FDPS) catalyzes the sequential condensation of isopentenyl diphosphate (IPP) with dimethylallyl diphosphate (DMAPP) and then with geranyl diphosphate to form FPP. This enzyme is a key node in the mevalonate pathway, and its activity determines the size of the FPP pool available for downstream branches. In Toxoplasma gondii, a bifunctional farnesyl-diphosphate/geranylgeranyl-diphosphate synthase performs this reaction and is targeted by bisphosphonates.
Branching into sterol and squalene biosynthesis
In simple terms: FPP is the starting material for making cholesterol and related sterols.
FPP is converted to squalene by squalene synthase, which is the first committed step in sterol biosynthesis. This branch leads to cholesterol, a essential component of cell membranes and a precursor for steroid hormones and bile acids. In plants, FPP is also a precursor for carotenoids and sesquiterpenes, and dedicated FPP synthases help partition flux between growth and defense.
Non-sterol isoprenoid branches
In simple terms: FPP is also used to make other important molecules besides cholesterol.
Beyond sterols, FPP is used for the synthesis of ubiquinone (coenzyme Q), dolichol, and heme A, which are vital for mitochondrial electron transport, protein glycosylation, and oxygen transport, respectively. These non-sterol branches compete with sterol synthesis for the common FPP pool, and their regulation is critical for cellular homeostasis.
Protein farnesylation
In simple terms: FPP is attached to certain proteins to help them stick to membranes.
FPP serves as a substrate for protein farnesyltransferases, which covalently attach a farnesyl group to cysteine residues in CAAX motifs of target proteins such as RAS and other small GTPases. This prenylation modification increases hydrophobicity and promotes membrane association, which is essential for the signaling functions of these proteins. In aged oocytes, mevalonate metabolites including FPP support prenylation of small GTPases to boost quality.
Regulation of FPP flux and compartmentalization
In simple terms: The cell controls where and how much FPP is made.
FPP metabolism is compartmentalized, with enzymes of the mevalonate pathway distributed between the cytosol, peroxisomes, and endoplasmic reticulum. This spatial organization allows separate regulation of sterol and non-sterol branches and ensures that FPP is directed to the appropriate downstream pathway. In neutrophils, a mevalonate metabolite/TRPM2/calcium signaling axis modulates inflammatory responses, indicating that FPP-related metabolites can influence calcium signaling.
Key Genes Involved in GO:0045338 farnesyl diphosphate metabolic process
The following genes and proteins are central to farnesyl diphosphate metabolic process, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| FDPS | Catalyzes synthesis of FPP from IPP and DMAPP | Therapeutic vulnerability in hepatocellular carcinoma |
| GGPS1 | Geranylgeranyl diphosphate synthase; can use FPP as substrate | Bifunctional FPP/GGPP synthase in Toxoplasma is drug target |
| SQLE | Squalene epoxidase; converts squalene to sterol precursors | Sterol biosynthesis branch downstream of FPP |
| FDFT1 | Squalene synthase; first committed step in sterol synthesis from FPP | Regulates flux from FPP to cholesterol |
| HMGCR | Rate-limiting enzyme of mevalonate pathway upstream of FPP | Target of statins; affects FPP pool |
| FNTA | Farnesyltransferase alpha subunit; prenylates proteins using FPP | Protein farnesylation of small GTPases |
| FNTB | Farnesyltransferase beta subunit; catalytic subunit | Protein farnesylation and membrane targeting |
| RAS | Small GTPase; farnesylated using FPP | Membrane localization and signaling |
| RHO | Small GTPase; prenylated using FPP or GGPP | Cytoskeletal regulation and oocyte quality |
| RAC1 | Small GTPase; prenylated | Cell migration and inflammation |
| TRPM2 | Calcium channel modulated by mevalonate metabolites | Inflammatory signaling in Behçet's disease |
| TNF | Cytokine targeted by inhibitors that affect mevalonate axis | Vasculitis in Behçet's disease |
| FDPS1 | Plant farnesyl diphosphate synthase | Sesquiterpene biosynthesis in tomato |
| FDPS2 | Dedicated FPP synthase in maize | Growth-defense tradeoffs |
| TPS | Terpene synthases using FPP for sesquiterpenes | Plant specialized metabolism |
| ERG9 | Squalene synthase in fungi | Ergosterol biosynthesis |
| COQ2 | Ubiquinone biosynthesis using FPP-derived polyprenyl | Mitochondrial function |
How Is farnesyl diphosphate metabolic process Regulated?
Farnesyl diphosphate metabolic process is regulated at multiple levels. The mevalonate pathway is controlled by feedback mechanisms, including sterol-mediated degradation of HMG-CoA reductase, which affects the supply of FPP. Compartmentalization of enzymes between peroxisomes, cytosol, and endoplasmic reticulum provides spatial regulation of FPP flux. In immune cells, a mevalonate metabolite/TRPM2/calcium signaling axis modulates neutrophil function, indicating that FPP-related metabolites can influence calcium-dependent pathways. In aged oocytes, prenylation of small GTPases by FPP-derived metabolites is linked to quality improvement, suggesting regulation by the mevalonate pathway. Additionally, in plants, dedicated FPP synthases are regulated to balance growth and defense.
farnesyl diphosphate metabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| FDPS | Hepatocellular carcinoma | FDPS knockout or overexpression in liver cancer cell lines |
| RAS | Cancer and developmental disorders | Point mutation of farnesylation site (CAAX) to block prenylation |
| TRPM2 | Behçet's disease vasculitis | TRPM2 knockout in neutrophils or endothelial cells |
| FDPS (Toxoplasma) | Parasitic infection | Bifunctional FDPS/GGPPS knockout in T. gondii |
| FDPS1/2 (plant) | Sesquiterpene biosynthesis | Knockout or overexpression in tomato or maize [4,5] |
Cancer
FDPS, the enzyme that synthesizes FPP, has been identified as a therapeutic vulnerability in hepatocellular carcinoma through single-cell mapping of cholesterol metabolism. Elevated FPP metabolism supports rapid proliferation by supplying sterols and prenylated proteins such as RAS, which drive oncogenic signaling [1,6]. Targeting FDPS or downstream prenylation enzymes may therefore offer therapeutic strategies in cancers dependent on mevalonate pathway flux.
Reproductive aging
Mevalonate metabolites, including FPP, boost aged oocyte quality through prenylation of small GTPases. This suggests that declining FPP metabolism or prenylation capacity may contribute to reproductive aging, and that supplementing mevalonate pathway intermediates could improve oocyte competence.
Inflammatory vasculitis
In Behçet's disease, TNF inhibitors target a mevalonate metabolite/TRPM2/calcium signaling axis in neutrophils to dampen vasculitis. This links FPP metabolism to inflammatory signaling and suggests that modulating this pathway could be beneficial in vasculitic disorders.
Parasitic infections
The bifunctional farnesyl-diphosphate/geranylgeranyl-diphosphate synthase of Toxoplasma gondii is a molecular target of bisphosphonates, indicating that FPP metabolism is essential for apicomplexan parasites and can be exploited for antiparasitic therapy.
From farnesyl diphosphate metabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does FDPS loss affect cancer cell proliferation? | FDPS knockout cell lines (e.g., HepG2, Huh7) |
| Does blocking farnesylation of RAS alter signaling? | Point mutation of RAS CAAX motif to prevent farnesylation |
| Can FPP metabolism be redirected to increase sesquiterpene production? | Knock-in or overexpression of dedicated FPP synthases in tomato |
| Is TRPM2 required for mevalonate metabolite-induced calcium signaling? | TRPM2 knockout neutrophils |
| Does FDPS inhibition affect Toxoplasma growth? | Bifunctional FDPS/GGPPS knockout or knockdown in T. gondii |
| Does FPP supplementation improve oocyte quality? | Overexpression of FDPS or addition of mevalonate metabolites in aged oocytes |
How to Study the farnesyl diphosphate metabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| LC-MS/MS metabolomics | Levels of FPP and isoprenoid intermediates | Quantifying pathway flux in cells |
| 13C isotope tracing | Flux through mevalonate pathway | Determining branch-point utilization |
| FDPS activity assay | Enzymatic conversion of IPP/DMAPP to FPP | Testing inhibitors like bisphosphonates |
| Prenylation labeling | Incorporation of farnesyl groups into proteins | Assessing small GTPase modification |
| Single-cell RNA-seq | Expression of FDPS and pathway genes | Identifying therapeutic vulnerabilities in cancer |
| CRISPR knockout screening | Gene essentiality in FPP metabolism | Discovering dependencies in cancer cells |
| Plant metabolic engineering | Sesquiterpene production | Enhancing specialized metabolites in crops |
| Parasite growth assays | Toxoplasma proliferation | Evaluating antiparasitic drugs |
Metabolomics and flux analysis
Mass spectrometry-based metabolomics can quantify FPP and related isoprenoids in cells and tissues, providing direct readouts of GO:0045338 activity. Stable isotope tracing with 13C-labeled precursors can measure flux through the mevalonate pathway and identify branch-point utilization.
Enzyme activity assays
FDPS enzyme activity can be measured using radiolabeled IPP and DMAPP substrates, followed by extraction and analysis of FPP products. Such assays are useful for testing inhibitors such as bisphosphonates in parasites.
Prenylation analysis
Protein farnesylation can be assessed by metabolic labeling with 3H-mevalonate or by immunoblotting for prenylated proteins. These methods help determine whether changes in FPP metabolism affect small GTPase membrane association.
Transcriptomics and single-cell mapping
RNA-seq and single-cell transcriptomics can reveal expression patterns of FDPS and other pathway genes in disease contexts, as shown in hepatocellular carcinoma. Such data can identify cell populations with altered FPP metabolism.
How CRISPR Can Be Used to Study GO:0045338 farnesyl diphosphate metabolic process
Knockout
CRISPR knockout of FDPS or other FPP metabolism genes can abolish FPP synthesis, leading to cholesterol auxotrophy and impaired prenylation. Such models are valuable for studying the essentiality of GO:0045338 in cancer cells and for validating therapeutic targets.
Point Mutation
Point mutations can be introduced into the catalytic site of FDPS or into the CAAX motif of farnesylated proteins like RAS to block prenylation without affecting other functions. These models help dissect the specific contribution of farnesylation to protein function.
Knock-in
Knock-in of tagged FDPS or fluorescent reporters allows visualization of FPP metabolism in live cells and tissues. Knock-in of dedicated FPP synthases in plants can redirect flux to sesquiterpene biosynthesis.
Overexpression
Overexpression of FDPS or upstream mevalonate pathway enzymes increases FPP availability and can enhance prenylation or sterol synthesis. In aged oocytes, boosting mevalonate metabolites improves quality, suggesting overexpression models can test sufficiency.
How EDITGENE Supports farnesyl diphosphate metabolic process Research
Researchers studying farnesyl diphosphate metabolic process-related genes often need to determine whether a candidate gene is causally involved in FPP synthesis, downstream branching, or prenylation-dependent signaling. EDITGENE provides CRISPR-based cell model services to enable such causal studies with precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for farnesyl diphosphate metabolic process research.
Frequently Asked Questions About farnesyl diphosphate metabolic process
What is farnesyl diphosphate metabolic process?
It is the set of chemical reactions and pathways involving farnesyl diphosphate (FPP), an intermediate in carotenoid, sesquiterpene, squalene and sterol biosynthesis, and a substrate for protein farnesylation.
What is the GO ID for farnesyl diphosphate metabolic process?
The Gene Ontology ID is GO:0045338, under biological_process.
What genes are involved in farnesyl diphosphate metabolic process?
Key genes include FDPS, GGPS1, FDFT1, SQLE, HMGCR, FNTA, FNTB, and small GTPases such as RAS and RHO [1,6,7].
Why is farnesyl diphosphate important in cancer?
FDPS, which synthesizes FPP, is a therapeutic vulnerability in hepatocellular carcinoma, and FPP supports prenylation of oncogenic proteins like RAS [1,6].
How is farnesyl diphosphate metabolism studied?
Common methods include LC-MS/MS metabolomics, isotope tracing, enzyme activity assays, prenylation labeling, and CRISPR screens [1,6,7,8].
What diseases are linked to farnesyl diphosphate metabolism?
Cancer, reproductive aging, Behçet's disease vasculitis, and parasitic infections such as toxoplasmosis [1,3,6,8].
What is the role of FDPS in farnesyl diphosphate metabolism?
FDPS catalyzes the synthesis of FPP from IPP and DMAPP, making it the central enzyme of this process.
Can farnesyl diphosphate metabolism be targeted therapeutically?
Yes, bisphosphonates target FDPS in parasites, and FDPS inhibition is being explored in cancer [6,8].
How does farnesyl diphosphate affect protein prenylation?
FPP is used by farnesyltransferases to attach a farnesyl group to proteins like RAS, promoting membrane localization.
What model systems are used to study farnesyl diphosphate metabolic process?
Models include cancer cell lines, aged oocytes, neutrophils, Toxoplasma gondii, and plants such as tomato and maize [1,3,4,5,6,8].
Conclusion
Farnesyl diphosphate metabolic process (GO:0045338) is a central metabolic pathway that supplies FPP for sterol and non-sterol isoprenoid biosynthesis and for protein farnesylation. Its dysregulation is implicated in cancer, reproductive aging, inflammatory vasculitis, and parasitic infections, making it a rich area for therapeutic and metabolic engineering research [1,3,6,8]. Understanding the genes and regulatory mechanisms of this process can guide the development of targeted interventions. EDITGENE provides comprehensive CRISPR cell model services, including knockout, point mutation, knock-in, overexpression, and library screening, to support mechanistic studies of GO:0045338 and its associated genes. By leveraging these tools, researchers can dissect the causal roles of FPP metabolism in health and disease.
References
- 1. Liu C et al.. 2025. Mevalonate metabolites boost aged oocyte quality through prenylation of small GTPases.. Nat Aging 5(10):2022-2038 PMID: 40858817
- 2. Tang YJ et al.. 2024. Cyclo-farnesyl Diphosphate-Dependent Prenylation in Fungi.. Org Lett 26(39):8366-8370 PMID: 39310987
- 3. Zhang M et al.. 2024. TNF inhibitors target a mevalonate metabolite/TRPM2/calcium signaling axis in neutrophils to dampen vasculitis in Behçet's disease.. Nat Commun 15(1):9261 PMID: 39461948
- 4. Tang HV et al.. 2022. Dedicated farnesyl diphosphate synthases circumvent isoprenoid-derived growth-defense tradeoffs in Zea mays.. Plant J 112(1):207-220 PMID: 35960639
- 5. Chen J et al.. 2023. Plastidial engineering with coupled farnesyl diphosphate pool reconstitution and enhancement for sesquiterpene biosynthesis in tomato fruit.. Metab Eng 77:41-52 PMID: 36893914
- 6. Yang X et al.. 2026. Single-cell mapping of cholesterol metabolism reveals FDPS as a therapeutic vulnerability in hepatocellular carcinoma.. Cell Oncol (Dordr) 49(2):47 PMID: 41706364
- 7. Krisans SK. 1996. Cell compartmentalization of cholesterol biosynthesis.. Ann N Y Acad Sci 804:142-64 PMID: 8993542
- 8. Ling Y et al.. 2007. The farnesyl-diphosphate/geranylgeranyl-diphosphate synthase of Toxoplasma gondii is a bifunctional enzyme and a molecular target of bisphosphonates.. J Biol Chem 282(42):30804-16 PMID: 17724033
